Slingshot members are tracking this event:

Phase 3 data of Iomab-B in Hematopoietic Stem Cells Transplantation to be presented at TCT meeting February 24, 2019, 12:30pm CT.

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
High Medium Low
Impact on Stocks
ATNM Community voting in process
Slingshot Insights Explained
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Iomab-b, Hematopoietic Stem Cell Transplantation, Tct, Phase 3 Study